Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation

We report the case of a 7-month-old female patient who developed acute megakaryoblastic leukemia 6 months after the appearance of skull bone lesions. Initial evaluation and diagnosis of this patient were challenging and only achieved thanks to genomic analysis by NGS (next generation sequencing). It...

Full description

Bibliographic Details
Main Authors: Miriam Gutiérrez-Jimeno, Elena Panizo-Morgado, Marta Calvo-Imirizaldu, Víctor Galán-Gómez, Adela Escudero-López, Ana Patiño-García
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.875510/full
_version_ 1828806050965356544
author Miriam Gutiérrez-Jimeno
Elena Panizo-Morgado
Marta Calvo-Imirizaldu
Víctor Galán-Gómez
Adela Escudero-López
Ana Patiño-García
Ana Patiño-García
author_facet Miriam Gutiérrez-Jimeno
Elena Panizo-Morgado
Marta Calvo-Imirizaldu
Víctor Galán-Gómez
Adela Escudero-López
Ana Patiño-García
Ana Patiño-García
author_sort Miriam Gutiérrez-Jimeno
collection DOAJ
description We report the case of a 7-month-old female patient who developed acute megakaryoblastic leukemia 6 months after the appearance of skull bone lesions. Initial evaluation and diagnosis of this patient were challenging and only achieved thanks to genomic analysis by NGS (next generation sequencing). It is unusual for the initial manifestation of acute megakaryoblastic leukemia to be a skull bone lesion. Extramedullary acute myeloid leukemia (eAML), also known as myeloid sarcoma (MS), often occurs simultaneously with acute myeloid leukemia (AML), although it may precede AML. Genomic analysis based on a NGS panel (Oncomine Childhood Cancer Research Assay) detected a RBM15::MKL1 fusion, a consequence of a t (1;22)(p13;q13) translocation, establishing the diagnosis of acute megakaryoblastic leukemia and enabling disease follow-up by qPCR. A diagnosis of eAML is built up from various findings in radiological, histological, immunophenotypic and genomic studies; when the tumor appears de novo, diagnosis is more complicated. We emphasize the importance of a multidisciplinary team in the initial approach to rare tumors and the use of genomic studies to contribute to the knowledge of these neoplasms, risk stratification and treatment planning.
first_indexed 2024-12-12T08:04:11Z
format Article
id doaj.art-ef6e9d2cbf174227b2930aa10574ebc8
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-12-12T08:04:11Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-ef6e9d2cbf174227b2930aa10574ebc82022-12-22T00:32:02ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602022-06-011010.3389/fped.2022.875510875510Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial ManifestationMiriam Gutiérrez-Jimeno0Elena Panizo-Morgado1Marta Calvo-Imirizaldu2Víctor Galán-Gómez3Adela Escudero-López4Ana Patiño-García5Ana Patiño-García6Department of Pediatrics, University Clinic of Navarra, Pamplona, SpainDepartment of Pediatrics, University Clinic of Navarra, Pamplona, SpainDivision of Neuroradiology, Department of Radiology, University Clinic of Navarra, Pamplona, SpainPediatric Hematology and Oncology Unit, Department of Pediatrics, La Paz University Hospital, Madrid, SpainPediatric Molecular Hemato-Oncology Section, Department of Genetics, Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital–IdiPAZ, Madrid, SpainDepartment of Pediatrics, University Clinic of Navarra, Pamplona, SpainSolid Tumor Program, CIMA, Center for Applied Medical Research and IdiSNA, Pamplona, SpainWe report the case of a 7-month-old female patient who developed acute megakaryoblastic leukemia 6 months after the appearance of skull bone lesions. Initial evaluation and diagnosis of this patient were challenging and only achieved thanks to genomic analysis by NGS (next generation sequencing). It is unusual for the initial manifestation of acute megakaryoblastic leukemia to be a skull bone lesion. Extramedullary acute myeloid leukemia (eAML), also known as myeloid sarcoma (MS), often occurs simultaneously with acute myeloid leukemia (AML), although it may precede AML. Genomic analysis based on a NGS panel (Oncomine Childhood Cancer Research Assay) detected a RBM15::MKL1 fusion, a consequence of a t (1;22)(p13;q13) translocation, establishing the diagnosis of acute megakaryoblastic leukemia and enabling disease follow-up by qPCR. A diagnosis of eAML is built up from various findings in radiological, histological, immunophenotypic and genomic studies; when the tumor appears de novo, diagnosis is more complicated. We emphasize the importance of a multidisciplinary team in the initial approach to rare tumors and the use of genomic studies to contribute to the knowledge of these neoplasms, risk stratification and treatment planning.https://www.frontiersin.org/articles/10.3389/fped.2022.875510/fullextramedullary acute myeloid leukemiamyeloid sarcomaacute megakaryoblastic leukemiagenomicsnext generation sequencing
spellingShingle Miriam Gutiérrez-Jimeno
Elena Panizo-Morgado
Marta Calvo-Imirizaldu
Víctor Galán-Gómez
Adela Escudero-López
Ana Patiño-García
Ana Patiño-García
Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation
Frontiers in Pediatrics
extramedullary acute myeloid leukemia
myeloid sarcoma
acute megakaryoblastic leukemia
genomics
next generation sequencing
title Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation
title_full Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation
title_fullStr Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation
title_full_unstemmed Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation
title_short Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation
title_sort case report the value of genomic analysis in a case of megakaryoblastic leukemia with atypical initial manifestation
topic extramedullary acute myeloid leukemia
myeloid sarcoma
acute megakaryoblastic leukemia
genomics
next generation sequencing
url https://www.frontiersin.org/articles/10.3389/fped.2022.875510/full
work_keys_str_mv AT miriamgutierrezjimeno casereportthevalueofgenomicanalysisinacaseofmegakaryoblasticleukemiawithatypicalinitialmanifestation
AT elenapanizomorgado casereportthevalueofgenomicanalysisinacaseofmegakaryoblasticleukemiawithatypicalinitialmanifestation
AT martacalvoimirizaldu casereportthevalueofgenomicanalysisinacaseofmegakaryoblasticleukemiawithatypicalinitialmanifestation
AT victorgalangomez casereportthevalueofgenomicanalysisinacaseofmegakaryoblasticleukemiawithatypicalinitialmanifestation
AT adelaescuderolopez casereportthevalueofgenomicanalysisinacaseofmegakaryoblasticleukemiawithatypicalinitialmanifestation
AT anapatinogarcia casereportthevalueofgenomicanalysisinacaseofmegakaryoblasticleukemiawithatypicalinitialmanifestation
AT anapatinogarcia casereportthevalueofgenomicanalysisinacaseofmegakaryoblasticleukemiawithatypicalinitialmanifestation